The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Smart Insulin Injection Pens Market Research Report 2025
Synopsis
The smart insulin injection pen is a reusable syringe pen with an intuitive smartphone app that helps people with diabetes better manage insulin delivery. This smart system calculates and tracks doses and provides helpful reminders, alerts and reports.
Global Smart Insulin Injection Pens market is projected to reach US$ 185.3 million in 2029, increasing from US$ 102.8 million in 2022, with the CAGR of 9.2% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Smart Insulin Injection Pens market research.
Smart insulin pens are an excellent option for treating diabetes as they allow diabetics to inject insulin. Smart insulin pens make it easier to deliver doses on a regular basis thanks to timely reminders and notifications from the system. Due to the ease of use, smart insulin pens are in increasing demand. In addition, the smart device can be flexibly combined with insulin pens already used by diabetics. Hence, the market for smart insulin pens is expanding as they help in delivering proper insulin doses with the option to send periodic reminders or timely warnings. The major growth channel for the smart insulin pen market during the forecast period will be the healthcare industry, including hospitals and clinics. When people have health problems, they often go to these places. Therefore, it is the first step in detecting diabetes. Rising prevalence of diabetes among geriatric patients is also driving the significant growth of the market throughout the forecast period. Due to the rapid development of social organizations and the increasing burden of the younger generation, the number of diabetic patients continues to increase. The increase in patients led to rapid sales of insulin products on the market. Recently, smart insulin pens have become popular gadgets. Demand for smart insulin pens has boosted sales as needlestick injuries have become more common. Busy and dynamic lifestyles make it difficult for people to exercise; thus, in recent years, a sedentary lifestyle has become the norm. This lifestyle change leading to diabetes creates a huge opportunity for the market during the forecast period.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Smart Insulin Injection Pens market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Emperra
Roche
Medtronic
Diamesco
Sanofi Aventis
Novo Nordisk
Insulet Corporation
Bigfoot Biomedical
Eli Lily
Spirit Healthcare
Pendiq
BioCorp
BerlinChemie
Segment by Type
Bluetooth Connected
USB Connected
Segment by Application
Clinics
Ambulatory Surgical Centers
Retail Pharmacies
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The Smart Insulin Injection Pens report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
The smart insulin injection pen is a reusable syringe pen with an intuitive smartphone app that helps people with diabetes better manage insulin delivery. This smart system calculates and tracks doses and provides helpful reminders, alerts and reports.
Global Smart Insulin Injection Pens market is projected to reach US$ 185.3 million in 2029, increasing from US$ 102.8 million in 2022, with the CAGR of 9.2% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Smart Insulin Injection Pens market research.
Smart insulin pens are an excellent option for treating diabetes as they allow diabetics to inject insulin. Smart insulin pens make it easier to deliver doses on a regular basis thanks to timely reminders and notifications from the system. Due to the ease of use, smart insulin pens are in increasing demand. In addition, the smart device can be flexibly combined with insulin pens already used by diabetics. Hence, the market for smart insulin pens is expanding as they help in delivering proper insulin doses with the option to send periodic reminders or timely warnings. The major growth channel for the smart insulin pen market during the forecast period will be the healthcare industry, including hospitals and clinics. When people have health problems, they often go to these places. Therefore, it is the first step in detecting diabetes. Rising prevalence of diabetes among geriatric patients is also driving the significant growth of the market throughout the forecast period. Due to the rapid development of social organizations and the increasing burden of the younger generation, the number of diabetic patients continues to increase. The increase in patients led to rapid sales of insulin products on the market. Recently, smart insulin pens have become popular gadgets. Demand for smart insulin pens has boosted sales as needlestick injuries have become more common. Busy and dynamic lifestyles make it difficult for people to exercise; thus, in recent years, a sedentary lifestyle has become the norm. This lifestyle change leading to diabetes creates a huge opportunity for the market during the forecast period.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Smart Insulin Injection Pens market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Emperra
Roche
Medtronic
Diamesco
Sanofi Aventis
Novo Nordisk
Insulet Corporation
Bigfoot Biomedical
Eli Lily
Spirit Healthcare
Pendiq
BioCorp
BerlinChemie
Segment by Type
Bluetooth Connected
USB Connected
Segment by Application
Clinics
Ambulatory Surgical Centers
Retail Pharmacies
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The Smart Insulin Injection Pens report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Smart Insulin Injection Pens Market Overview
1.1 Product Overview and Scope of Smart Insulin Injection Pens
1.2 Smart Insulin Injection Pens Segment by Type
1.2.1 Global Smart Insulin Injection Pens Market Value Comparison by Type (2023-2029)
1.2.2 Bluetooth Connected
1.2.3 USB Connected
1.3 Smart Insulin Injection Pens Segment by Application
1.3.1 Global Smart Insulin Injection Pens Market Value by Application: (2023-2029)
1.3.2 Clinics
1.3.3 Ambulatory Surgical Centers
1.3.4 Retail Pharmacies
1.3.5 Others
1.4 Global Smart Insulin Injection Pens Market Size Estimates and Forecasts
1.4.1 Global Smart Insulin Injection Pens Revenue 2018-2029
1.4.2 Global Smart Insulin Injection Pens Sales 2018-2029
1.4.3 Global Smart Insulin Injection Pens Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Smart Insulin Injection Pens Market Competition by Manufacturers
2.1 Global Smart Insulin Injection Pens Sales Market Share by Manufacturers (2018-2023)
2.2 Global Smart Insulin Injection Pens Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Smart Insulin Injection Pens Average Price by Manufacturers (2018-2023)
2.4 Global Smart Insulin Injection Pens Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Smart Insulin Injection Pens, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Smart Insulin Injection Pens, Product Type & Application
2.7 Smart Insulin Injection Pens Market Competitive Situation and Trends
2.7.1 Smart Insulin Injection Pens Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Smart Insulin Injection Pens Players Market Share by Revenue
2.7.3 Global Smart Insulin Injection Pens Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Smart Insulin Injection Pens Retrospective Market Scenario by Region
3.1 Global Smart Insulin Injection Pens Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Smart Insulin Injection Pens Global Smart Insulin Injection Pens Sales by Region: 2018-2029
3.2.1 Global Smart Insulin Injection Pens Sales by Region: 2018-2023
3.2.2 Global Smart Insulin Injection Pens Sales by Region: 2024-2029
3.3 Global Smart Insulin Injection Pens Global Smart Insulin Injection Pens Revenue by Region: 2018-2029
3.3.1 Global Smart Insulin Injection Pens Revenue by Region: 2018-2023
3.3.2 Global Smart Insulin Injection Pens Revenue by Region: 2024-2029
3.4 North America Smart Insulin Injection Pens Market Facts & Figures by Country
3.4.1 North America Smart Insulin Injection Pens Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Smart Insulin Injection Pens Sales by Country (2018-2029)
3.4.3 North America Smart Insulin Injection Pens Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Smart Insulin Injection Pens Market Facts & Figures by Country
3.5.1 Europe Smart Insulin Injection Pens Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Smart Insulin Injection Pens Sales by Country (2018-2029)
3.5.3 Europe Smart Insulin Injection Pens Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Smart Insulin Injection Pens Market Facts & Figures by Country
3.6.1 Asia Pacific Smart Insulin Injection Pens Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Smart Insulin Injection Pens Sales by Country (2018-2029)
3.6.3 Asia Pacific Smart Insulin Injection Pens Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Smart Insulin Injection Pens Market Facts & Figures by Country
3.7.1 Latin America Smart Insulin Injection Pens Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Smart Insulin Injection Pens Sales by Country (2018-2029)
3.7.3 Latin America Smart Insulin Injection Pens Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Smart Insulin Injection Pens Market Facts & Figures by Country
3.8.1 Middle East and Africa Smart Insulin Injection Pens Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Smart Insulin Injection Pens Sales by Country (2018-2029)
3.8.3 Middle East and Africa Smart Insulin Injection Pens Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Smart Insulin Injection Pens Sales by Type (2018-2029)
4.1.1 Global Smart Insulin Injection Pens Sales by Type (2018-2023)
4.1.2 Global Smart Insulin Injection Pens Sales by Type (2024-2029)
4.1.3 Global Smart Insulin Injection Pens Sales Market Share by Type (2018-2029)
4.2 Global Smart Insulin Injection Pens Revenue by Type (2018-2029)
4.2.1 Global Smart Insulin Injection Pens Revenue by Type (2018-2023)
4.2.2 Global Smart Insulin Injection Pens Revenue by Type (2024-2029)
4.2.3 Global Smart Insulin Injection Pens Revenue Market Share by Type (2018-2029)
4.3 Global Smart Insulin Injection Pens Price by Type (2018-2029)
5 Segment by Application
5.1 Global Smart Insulin Injection Pens Sales by Application (2018-2029)
5.1.1 Global Smart Insulin Injection Pens Sales by Application (2018-2023)
5.1.2 Global Smart Insulin Injection Pens Sales by Application (2024-2029)
5.1.3 Global Smart Insulin Injection Pens Sales Market Share by Application (2018-2029)
5.2 Global Smart Insulin Injection Pens Revenue by Application (2018-2029)
5.2.1 Global Smart Insulin Injection Pens Revenue by Application (2018-2023)
5.2.2 Global Smart Insulin Injection Pens Revenue by Application (2024-2029)
5.2.3 Global Smart Insulin Injection Pens Revenue Market Share by Application (2018-2029)
5.3 Global Smart Insulin Injection Pens Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Emperra
6.1.1 Emperra Corporation Information
6.1.2 Emperra Description and Business Overview
6.1.3 Emperra Smart Insulin Injection Pens Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Emperra Smart Insulin Injection Pens Product Portfolio
6.1.5 Emperra Recent Developments/Updates
6.2 Roche
6.2.1 Roche Corporation Information
6.2.2 Roche Description and Business Overview
6.2.3 Roche Smart Insulin Injection Pens Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Roche Smart Insulin Injection Pens Product Portfolio
6.2.5 Roche Recent Developments/Updates
6.3 Medtronic
6.3.1 Medtronic Corporation Information
6.3.2 Medtronic Description and Business Overview
6.3.3 Medtronic Smart Insulin Injection Pens Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Medtronic Smart Insulin Injection Pens Product Portfolio
6.3.5 Medtronic Recent Developments/Updates
6.4 Diamesco
6.4.1 Diamesco Corporation Information
6.4.2 Diamesco Description and Business Overview
6.4.3 Diamesco Smart Insulin Injection Pens Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Diamesco Smart Insulin Injection Pens Product Portfolio
6.4.5 Diamesco Recent Developments/Updates
6.5 Sanofi Aventis
6.5.1 Sanofi Aventis Corporation Information
6.5.2 Sanofi Aventis Description and Business Overview
6.5.3 Sanofi Aventis Smart Insulin Injection Pens Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Sanofi Aventis Smart Insulin Injection Pens Product Portfolio
6.5.5 Sanofi Aventis Recent Developments/Updates
6.6 Novo Nordisk
6.6.1 Novo Nordisk Corporation Information
6.6.2 Novo Nordisk Description and Business Overview
6.6.3 Novo Nordisk Smart Insulin Injection Pens Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Novo Nordisk Smart Insulin Injection Pens Product Portfolio
6.6.5 Novo Nordisk Recent Developments/Updates
6.7 Insulet Corporation
6.6.1 Insulet Corporation Corporation Information
6.6.2 Insulet Corporation Description and Business Overview
6.6.3 Insulet Corporation Smart Insulin Injection Pens Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Insulet Corporation Smart Insulin Injection Pens Product Portfolio
6.7.5 Insulet Corporation Recent Developments/Updates
6.8 Bigfoot Biomedical
6.8.1 Bigfoot Biomedical Corporation Information
6.8.2 Bigfoot Biomedical Description and Business Overview
6.8.3 Bigfoot Biomedical Smart Insulin Injection Pens Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Bigfoot Biomedical Smart Insulin Injection Pens Product Portfolio
6.8.5 Bigfoot Biomedical Recent Developments/Updates
6.9 Eli Lily
6.9.1 Eli Lily Corporation Information
6.9.2 Eli Lily Description and Business Overview
6.9.3 Eli Lily Smart Insulin Injection Pens Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Eli Lily Smart Insulin Injection Pens Product Portfolio
6.9.5 Eli Lily Recent Developments/Updates
6.10 Spirit Healthcare
6.10.1 Spirit Healthcare Corporation Information
6.10.2 Spirit Healthcare Description and Business Overview
6.10.3 Spirit Healthcare Smart Insulin Injection Pens Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Spirit Healthcare Smart Insulin Injection Pens Product Portfolio
6.10.5 Spirit Healthcare Recent Developments/Updates
6.11 Pendiq
6.11.1 Pendiq Corporation Information
6.11.2 Pendiq Smart Insulin Injection Pens Description and Business Overview
6.11.3 Pendiq Smart Insulin Injection Pens Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Pendiq Smart Insulin Injection Pens Product Portfolio
6.11.5 Pendiq Recent Developments/Updates
6.12 BioCorp
6.12.1 BioCorp Corporation Information
6.12.2 BioCorp Smart Insulin Injection Pens Description and Business Overview
6.12.3 BioCorp Smart Insulin Injection Pens Sales, Revenue and Gross Margin (2018-2023)
6.12.4 BioCorp Smart Insulin Injection Pens Product Portfolio
6.12.5 BioCorp Recent Developments/Updates
6.13 BerlinChemie
6.13.1 BerlinChemie Corporation Information
6.13.2 BerlinChemie Smart Insulin Injection Pens Description and Business Overview
6.13.3 BerlinChemie Smart Insulin Injection Pens Sales, Revenue and Gross Margin (2018-2023)
6.13.4 BerlinChemie Smart Insulin Injection Pens Product Portfolio
6.13.5 BerlinChemie Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Smart Insulin Injection Pens Industry Chain Analysis
7.2 Smart Insulin Injection Pens Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Smart Insulin Injection Pens Production Mode & Process
7.4 Smart Insulin Injection Pens Sales and Marketing
7.4.1 Smart Insulin Injection Pens Sales Channels
7.4.2 Smart Insulin Injection Pens Distributors
7.5 Smart Insulin Injection Pens Customers
8 Smart Insulin Injection Pens Market Dynamics
8.1 Smart Insulin Injection Pens Industry Trends
8.2 Smart Insulin Injection Pens Market Drivers
8.3 Smart Insulin Injection Pens Market Challenges
8.4 Smart Insulin Injection Pens Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
